EyePoint (EYPT) vs Harvard Bioscience (HBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Harvard Bioscience (HBIO) has outperformed EyePoint (EYPT) over the past year, gaining 84.8% versus a loss of 75.1%. Over five years, EYPT leads with a -69.8% price change compared with -88.1% for HBIO. EyePoint is the larger company by market cap ($290.1 million vs $37.0 million), about 7.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EYPT | HBIO |
|---|---|---|
| Share price | $3.46 | $8.13 |
| Market cap | $290.09M | $37.01M |
| 1-day change | +4.22% | -4.35% |
| YTD return | -81.06% | +21.34% |
| 1-year return | -75.07% | +84.77% |
| 5-year return | -69.76% | -88.11% |
| Forward P/E | — | 12.60 |
| EPS (TTM) | $-3.75 | $-2.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.11 | $9.40 |
| 52-week low | $3.05 | $3.80 |
| Distance from 52-week high | -81.89% | -13.51% |
| Analyst consensus | none | none |
| Avg. price target upside | +648.84% | -7.75% |
| Average volume | 3.96M | 17.98K |
| Shares outstanding | 83.84M | 4.55M |
| Employees | 214 | 316 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EyePoint is about 7.8 times larger than Harvard Bioscience by market value ($290.09M vs $37.01M).
- HBIO has outperformed EYPT by 159.8 percentage points over the past year.
About EyePoint
EYPT stock →EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Industrials · Biotechnology: Laboratory Analytical Instruments · 214 employees
About Harvard Bioscience
HBIO stock →Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.
Industrials · Biotechnology: Laboratory Analytical Instruments · 316 employees
EYPT vs HBIO FAQ
Which is bigger, EyePoint or Harvard Bioscience?
EyePoint (EYPT) is larger, with a market capitalization of $290.09M compared with $37.01M for Harvard Bioscience (HBIO).
Which stock has performed better over the past year, EYPT or HBIO?
HBIO returned +84.77% over the past 12 months, compared with -75.07% for EYPT (price return, excluding dividends). Past performance does not predict future results.
Are EyePoint and Harvard Bioscience in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.